$22.74
-5.72-20.10%
At Close: -
$22.70
-0.04-0.18%
After Hours: 7:26 PM EDT
15 minutes delayed
Pacira BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacira BioSciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PCRX | Pacira BioSciences | $0.78 | $0.68 | — | — | $169.47M | $171.31M | — | — | 07/31/2024 | Get Alert |
PCRX | Pacira BioSciences | $0.53 | $0.62 | $0.62 | 0.00% | $160.34M | $165.35M | $167.12M | 1.07% | 05/07/2024 | Get Alert |
PCRX | Pacira BioSciences | $0.80 | $0.88 | $0.89 | 1.14% | $171.96M | $181.66M | $181.24M | -0.23% | 02/29/2024 | Get Alert |
PCRX | Pacira BioSciences | $0.64 | $0.79 | $0.72 | -8.86% | $167.47M | $173.00M | $163.93M | -5.25% | 11/02/2023 | Get Alert |
PCRX | Pacira BioSciences | $0.51 | $0.81 | $0.78 | -3.70% | $169.41M | $175.64M | $169.47M | -3.51% | 08/02/2023 | Get Alert |
PCRX | Pacira BioSciences | $0.64 | $0.62 | $0.53 | -14.52% | $157.99M | $158.84M | $160.34M | 0.94% | 05/03/2023 | Get Alert |
PCRX | Pacira BioSciences | $0.97 | $0.83 | $0.80 | -3.61% | $159.19M | $173.50M | $171.96M | -0.89% | 02/28/2023 | Get Alert |
PCRX | Pacira BioSciences | $0.72 | $0.76 | $0.64 | -15.79% | $127.72M | $168.89M | $167.47M | -0.84% | 11/03/2022 | Get Alert |
PCRX | Pacira BioSciences | $0.77 | $0.88 | $0.51 | -42.05% | $135.59M | $171.43M | $169.41M | -1.18% | 08/03/2022 | Get Alert |
PCRX | Pacira BioSciences | $0.53 | $0.83 | $0.64 | -22.89% | $119.03M | $159.49M | $157.99M | -0.94% | 05/04/2022 | Get Alert |
PCRX | Pacira BioSciences | $0.87 | $0.90 | $0.97 | 7.78% | $130.97M | $155.74M | $159.19M | 2.22% | 02/24/2022 | Get Alert |
PCRX | Pacira BioSciences | $0.68 | $0.65 | $0.72 | 10.77% | $117.48M | $130.38M | $127.72M | -2.04% | 11/03/2021 | Get Alert |
PCRX | Pacira BioSciences | $0.12 | $0.69 | $0.77 | 11.59% | $75.50M | $128.01M | $135.59M | 5.92% | 08/03/2021 | Get Alert |
PCRX | Pacira BioSciences | $0.53 | $0.63 | $0.53 | -15.87% | $105.68M | $119.28M | $119.03M | -0.21% | 05/04/2021 | Get Alert |
PCRX | Pacira BioSciences | $0.56 | $0.81 | $0.87 | 7.41% | $122.42M | $131.57M | $130.97M | -0.45% | 02/25/2021 | Get Alert |
PCRX | Pacira BioSciences | $0.48 | $0.61 | $0.68 | 11.48% | $104.69M | $115.15M | $117.48M | 2.03% | 10/29/2020 | Get Alert |
PCRX | Pacira BioSciences | $0.41 | $0.09 | $0.12 | 33.33% | $102.60M | $72.46M | $75.50M | 4.20% | 08/06/2020 | Get Alert |
PCRX | Pacira BioSciences | $0.22 | $0.32 | $0.53 | 65.62% | $91.31M | $102.97M | $105.68M | 2.64% | 05/07/2020 | Get Alert |
PCRX | Pacira BioSciences | $0.47 | $0.44 | $0.56 | 27.27% | $95.11M | $121.28M | $122.42M | — | 02/20/2020 | Get Alert |
PCRX | Pacira BioSciences | $0.31 | $0.33 | $0.48 | 45.45% | $83.45M | $104.89M | $104.69M | -0.20% | 11/07/2019 | Get Alert |
PCRX | Pacira BioSciences | $0.24 | $0.34 | $0.41 | 20.59% | $84.11M | $100.52M | $102.60M | 2.07% | 08/08/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $0.62 | $0.62 | 0.00 % |
Dec 2023 | 2024-02-29 | $0.89 | $0.88 | 1.14 % |
Sep 2023 | 2023-11-02 | $0.72 | $0.79 | -8.86 % |
Jun 2023 | 2023-08-02 | $0.78 | $0.81 | -3.70 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $167.12M | $165.35M | 1.07 % |
Dec 2023 | 2024-02-29 | $181.24M | $181.66M | -0.23 % |
Sep 2023 | 2023-11-02 | $163.93M | $173.00M | -5.25 % |
Jun 2023 | 2023-08-02 | $169.47M | $175.64M | -3.51 % |
Pacira BioSciences (PCRX) is scheduled to report earnings on July 31, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
The Actual EPS was $0.62, which hit the estimate of $0.62.
The Actual Revenue was $167.1M, which beat the estimate of $165.3M.
Browse earnings estimates, EPS, and revenue on all stocks.